Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Towards a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multi-center study (CTCTrap).

Andree KC, Mentink A, Zeune LL, Terstappen LWMM, Stoecklein NH, Neves RP, Driemel C, Lampignano R, Yang L, Neubauer H, Fehm T, Fischer JC, Rossi E, Manicone M, Basso U, Marson P, Zamarchi R, Loriot Y, Lapierre V, Faugeroux V, Oulhen M, Farace F, Fowler G, Sousa Fontes M, Ebbs B, Lambros M, Crespo M, Flohr P, de Bono JS.

Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31752. [Epub ahead of print]

PMID:
30006930
2.

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer-ready for prime-time?

Pailler E, Faugeroux V, Oulhen M, Catelain C, Farace F.

Transl Lung Cancer Res. 2017 Aug;6(4):444-453. doi: 10.21037/tlcr.2017.07.01. Review.

3.

Filter-Adapted Fluorescent In Situ Hybridization (FA-FISH) for Filtration-Enriched Circulating Tumor Cells.

Oulhen M, Pailler E, Faugeroux V, Farace F.

Methods Mol Biol. 2017;1634:133-141. doi: 10.1007/978-1-4939-7144-2_10.

PMID:
28819846
4.

A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.

Lindsay CR, Faugeroux V, Michiels S, Pailler E, Facchinetti F, Ou D, Bluthgen MV, Pannet C, Ngo-Camus M, Bescher G, Caramella C, Billiot F, Remon J, Planchard D, Soria JC, Besse B, Farace F.

Ann Oncol. 2017 Jul 1;28(7):1523-1531. doi: 10.1093/annonc/mdx156.

PMID:
28633480
5.

Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer.

Catelain C, Pailler E, Oulhen M, Faugeroux V, Pommier AL, Farace F.

Adv Exp Med Biol. 2017;994:169-179. doi: 10.1007/978-3-319-55947-6_9. Review.

PMID:
28560674
6.

Method for semi-automated microscopy of filtration-enriched circulating tumor cells.

Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, Laplace-Builhé C, Besse B, Loriot Y, Ngo-Camus M, Hemanda M, Lindsay CR, Soria JC, Vielh P, Farace F.

BMC Cancer. 2016 Jul 14;16:477. doi: 10.1186/s12885-016-2461-4.

7.

The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer.

Ross K, Pailler E, Faugeroux V, Taylor M, Oulhen M, Auger N, Planchard D, Soria JC, Lindsay CR, Besse B, Vielh P, Farace F.

Expert Rev Mol Diagn. 2015;15(12):1605-29. doi: 10.1586/14737159.2015.1111139. Epub 2015 Nov 13. Review.

PMID:
26564313
8.

Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer.

Faugeroux V, Pailler E, Auger N, Taylor M, Farace F.

Front Oncol. 2014 Nov 5;4:281. doi: 10.3389/fonc.2014.00281. eCollection 2014. Review.

9.

Synthesis and biological evaluation of conformationally constrained analogues of the antitubercular agent ethambutol.

Faugeroux V, Génisson Y, Salma Y, Constant P, Baltas M.

Bioorg Med Chem. 2007 Sep 1;15(17):5866-76. Epub 2007 Jun 2.

PMID:
17566744
10.

C-Alkyl 5-membered ring imino sugars as new potent cytotoxic glucosylceramide synthase inhibitors.

Faugeroux V, Génisson Y, Andrieu-Abadie N, Colié S, Levade T, Baltas M.

Org Biomol Chem. 2006 Dec 21;4(24):4437-9. Epub 2006 Nov 2.

PMID:
17268635
11.

Stereoselective access to the versatile 4-aminohex-5-ene-1,2,3-triol pattern.

Ayad T, Faugeroux V, Génisson Y, André C, Baltas M, Gorrichon L.

J Org Chem. 2004 Dec 10;69(25):8775-9.

PMID:
15575756

Supplemental Content

Loading ...
Support Center